220 related articles for article (PubMed ID: 28499934)
21. Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis.
Ma W; Zhang M; Liu S; Wang M; Shi Y; Yang T; Li X; Zhu L
Neurosci Lett; 2020 Jan; 715():134599. PubMed ID: 31722234
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Zhang S; Kan QC; Xu Y; Zhang GX; Zhu L
Mediators Inflamm; 2013; 2013():736085. PubMed ID: 24194630
[TBL] [Abstract][Full Text] [Related]
23. Matrine treatment induced an A2 astrocyte phenotype and protected the blood-brain barrier in CNS autoimmunity.
Jing Y; Ma R; Chu Y; Dou M; Wang M; Li X; Zhu L
J Chem Neuroanat; 2021 Nov; 117():102004. PubMed ID: 34280490
[TBL] [Abstract][Full Text] [Related]
24. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.
Zheng M; Liu Z; Mana L; Qin G; Huang S; Gong Z; Tian M; He Y; Wang P
J Ethnopharmacol; 2021 Oct; 278():114264. PubMed ID: 34082015
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis.
Liu N; Kan QC; Zhang XJ; Xv YM; Zhang S; Zhang GX; Zhu L
Exp Mol Pathol; 2014 Dec; 97(3):470-6. PubMed ID: 25303900
[TBL] [Abstract][Full Text] [Related]
26. Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS.
Dou M; Zhou X; Li L; Zhang M; Wang W; Wang M; Jing Y; Ma R; Zhao J; Zhu L
Front Immunol; 2021; 12():640778. PubMed ID: 33912166
[TBL] [Abstract][Full Text] [Related]
27. Matrine exerts anti‑breast cancer activity by mediating apoptosis and protective autophagy via the AKT/mTOR pathway in MCF‑7 cells.
Du J; Li J; Song D; Li Q; Li L; Li B; Li L
Mol Med Rep; 2020 Nov; 22(5):3659-3666. PubMed ID: 33000249
[TBL] [Abstract][Full Text] [Related]
28. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
29. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice.
Sun JJ; Ren QG; Xu L; Zhang ZJ
Sci Rep; 2015 Sep; 5():14235. PubMed ID: 26383267
[TBL] [Abstract][Full Text] [Related]
30. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
31. Neuregulin-1 converts reactive astrocytes toward oligodendrocyte lineage cells via upregulating the PI3K-AKT-mTOR pathway to repair spinal cord injury.
Ding Z; Dai C; Zhong L; Liu R; Gao W; Zhang H; Yin Z
Biomed Pharmacother; 2021 Feb; 134():111168. PubMed ID: 33395598
[TBL] [Abstract][Full Text] [Related]
32. Matrine alleviates early brain injury after experimental subarachnoid hemorrhage in rats: possible involvement of PI3K/Akt-mediated NF-κB inhibition and Keap1/Nrf2-dependent HO-1 inductionn.
Liu X; Zhang X; Ma K; Zhang R; Hou P; Sun B; Yuan S; Wang Z; Liu Z
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):38-44. PubMed ID: 27755950
[TBL] [Abstract][Full Text] [Related]
33. Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Kan QC; Pan QX; Zhang XJ; Chu YJ; Liu N; Lv P; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Oct; 99(2):212-9. PubMed ID: 26093163
[TBL] [Abstract][Full Text] [Related]
34. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.
Narayanan SP; Flores AI; Wang F; Macklin WB
J Neurosci; 2009 May; 29(21):6860-70. PubMed ID: 19474313
[TBL] [Abstract][Full Text] [Related]
35. Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period.
Sanadgol N; Barati M; Houshmand F; Hassani S; Clarner T; Shahlaei M; Golab F
Pharmacol Rep; 2020 Jun; 72(3):641-658. PubMed ID: 32048246
[TBL] [Abstract][Full Text] [Related]
36. Autophagy inhibition enhances Matrine derivative MASM induced apoptosis in cancer cells via a mechanism involving reactive oxygen species-mediated PI3K/Akt/mTOR and Erk/p38 signaling.
Zou Y; Sarem M; Xiang S; Hu H; Xu W; Shastri VP
BMC Cancer; 2019 Oct; 19(1):949. PubMed ID: 31615459
[TBL] [Abstract][Full Text] [Related]
37. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
[TBL] [Abstract][Full Text] [Related]
38. Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination.
Wahl SE; McLane LE; Bercury KK; Macklin WB; Wood TL
J Neurosci; 2014 Mar; 34(13):4453-65. PubMed ID: 24671992
[TBL] [Abstract][Full Text] [Related]
39. Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88/PI3K/Akt/NF-κB signalling pathway.
Zheng K; Lv B; Wu L; Wang C; Xu H; Li X; Wu Z; Zhao Y; Zheng Z
Bioengineered; 2022 Apr; 13(4):9322-9344. PubMed ID: 35287559
[TBL] [Abstract][Full Text] [Related]
40. mTORC2 Loss in Oligodendrocyte Progenitor Cells Results in Regional Hypomyelination in the Central Nervous System.
Dahl KD; Almeida AR; Hathaway HA; Bourne J; Brown TL; Finseth LT; Wood TL; Macklin WB
J Neurosci; 2023 Jan; 43(4):540-558. PubMed ID: 36460463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
